KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Esperion Therapeutics (ESPR) Asset Utilization Ratio (2019 - 2026)

Esperion Therapeutics filings provide 7 years of Asset Utilization Ratio readings, the most recent being 0.97 for Q4 2025.

  • On a quarterly basis, Asset Utilization Ratio fell 3.83% to 0.97 in Q4 2025 year-over-year; TTM through Dec 2025 was 0.97, a 3.83% decrease, with the full-year FY2025 number at 1.0, down 17.66% from a year prior.
  • Asset Utilization Ratio hit 0.97 in Q4 2025 for Esperion Therapeutics, up from 0.85 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 1.01 in Q4 2024 to a low of 0.21 in Q2 2022.
  • Median Asset Utilization Ratio over the past 5 years was 0.5 (2023), compared with a mean of 0.55.
  • The widest YoY moves for Asset Utilization Ratio: up 2945.93% in 2021, down 73.77% in 2021.
  • Esperion Therapeutics' Asset Utilization Ratio stood at 0.26 in 2021, then rose by 4.12% to 0.27 in 2022, then soared by 102.37% to 0.54 in 2023, then surged by 85.43% to 1.01 in 2024, then decreased by 3.83% to 0.97 in 2025.
  • The last three reported values for Asset Utilization Ratio were 0.97 (Q4 2025), 0.85 (Q3 2025), and 0.8 (Q2 2025) per Business Quant data.